Health · 6 views
Iron-based MRI agent detects and slows heart scarring in lab-grown human tissue
The Biomolecular Nanotechnology research group led by Ikerbasque research professor Aitziber L. Cortajarena has developed a new iron-based contrast agent for magnetic resonance imaging that can be used for both diagnosis and treatment.
Summary
The Biomolecular Nanotechnology research group led by Ikerbasque research professor Aitziber L. Cortajarena has developed a new iron-based contrast agent for magnetic resonance imaging that can be used for both diagnosis and treatment. In a study carried out on lab-grown human heart tissue, it was proven that the contrast agent accumulates in the fibrotic tissue, that its signal intensity on the MRI image increases with the severity of the disease, and that it slows disease progression.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Vitamin-carrying protein pathway shows promise for brain drug deliveryContinue reading
- Genetic testing may help identify inherited blood disorder carrier status earlierContinue reading
- Chemo-Free First-Line Treatment Yields Huge PFS Gain in dMMR Endometrial CancerContinue reading
- Jalen Hurts and the Corporate Compromise of Team PhysiciansContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow